MIT Technology Review Insights and Globant Report Rapid Agentic AI Uptake in Pharma

Nov 13, 2025
A new report by MIT Technology Review Insights and Globant finds that nearly three quarters of global pharmaceutical organizations are piloting or deploying agentic AI, with top use cases in compliance, data integration, and patient support.

Nearly three quarters of global pharmaceutical organizations are piloting or deploying agentic AI, according to a press release from MIT Technology Review Insights and Globant. The study, based on responses from 250 pharma leaders, highlights rapid adoption of AI agents across commercial and medical operations.

The report identifies regulatory compliance (51%), data standardization (49%), patient support (46%), and market intelligence (46%) as the leading areas of focus. It notes that 84% of respondents consider data standardization and integration a high or medium priority to enable AI agents to deliver value.

The findings suggest that pharmaceutical companies are moving beyond experimentation toward operational deployment of AI systems, with early adopters targeting improved efficiency and insight generation across core business functions.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.